Company Filing History:
Years Active: 2010-2021
Title: The Innovations of Keith A. Bostian
Introduction
Keith A. Bostian is a notable inventor based in Atherton, California, with a significant contribution to the field of antimicrobial agents. He holds a total of 17 patents, showcasing his dedication to advancing medical technology and improving treatment options for bacterial infections.
Latest Patents
Among his latest patents, Bostian has developed formulations of aerosolized fluoroquinolones suitable for treating pulmonary bacterial infections. One of his key inventions involves inhaled levofloxacin, specifically formulated for effective delivery to the lungs. This patent outlines methods for inhalation protocols and manufacturing procedures for the production and use of these compositions. Another significant patent focuses on aerosol fluoroquinolone formulations that incorporate divalent or trivalent cations, enhancing pulmonary availability for managing bacterial infections of the lung and upper respiratory tract.
Career Highlights
Bostian has worked with several companies throughout his career, including Mpex Pharmaceuticals, Inc. and Horizon Orphan LLC. His work in these organizations has contributed to the development of innovative treatments and has positioned him as a leader in his field.
Collaborations
Throughout his career, Bostian has collaborated with notable professionals, including Mark William Surber and David C. Griffith. These partnerships have fostered a collaborative environment that has led to significant advancements in antimicrobial research.
Conclusion
Keith A. Bostian's contributions to the field of antimicrobial agents through his innovative patents and collaborations highlight his impact on medical science. His work continues to pave the way for improved treatments for bacterial infections, demonstrating the importance of innovation in healthcare.